ATAI's merger with Eli Lilly clears US HSR and UK CMA; Australian waiting period expires Sept 10

AtaiBeckley Inc.

US HSR waiting period for ATAI-Eli Lilly merger expired at 11:59 p.m. ET on Aug 28, 2026.
UK CMA responded Aug 21, 2026, indicating no further questions on the merger briefing.
Australian ACCC determined Aug 27, 2026, merger may proceed subject to 14-day waiting period expiring Sept 10, 2026 at 10:00 a.m. ET.
Merger agreement dated July 15, 2026; ATAI to become wholly owned subsidiary of Eli Lilly.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.